Active Ingredients from Chinese Medicine for Combination Cancer Therapy

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2023 Jul 27

PMID 37497002

Authors

Xuan Wang

Jing Li

Ruie Chen

Ting Li

Meiwan Chen

Affiliations

Soon will be listed here.

Abstract

Combination therapy against cancer has gained increasing attention because it can help to target multiple pathways to tackle oncologic progression and improve the limited antitumor effect of single-agent therapy. Chinese medicine has been studied extensively in cancer therapy and proven to be efficacious in many cases due to its wide spectrum of anticancer activities. In this review, we aim to summarize the recent progress of active ingredients from Chinese medicine (AIFCM) in combination with various cancer therapeutic modalities, including chemotherapy, gene therapy, radiotherapy, phototherapy and immunotherapy. In addition to highlighting the potential contribution of AIFCM in combination cancer therapy, we also elucidate the underlying mechanisms behind their synergistic effect and improved anticancer efficacy, thereby encouraging the inclusion of these AIFCM as part of effective armamentarium in fighting intractable cancers. Finally, we present the challenges and future perspectives of AIFCM combination therapy as a feasible and promising strategy for the optimization of cancer treatment and better clinical outcomes.

Citing Articles

Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells.

Cao Y, Wang S, Ma J, Long M, Ma X, Yang X Cell Death Dis. 2024; 15(12):931.

PMID: 39719443 PMC: 11668892. DOI: 10.1038/s41419-024-07321-1.

Recent Trends in anti-tumor mechanisms and molecular targets of celastrol.

Zhu Y, Meng Y, Zhang J, Liu R, Shen S, Gu L Int J Biol Sci. 2024; 20(14):5510-5530.

PMID: 39494324 PMC: 11528459. DOI: 10.7150/ijbs.99592.

Peimine induces apoptosis of glioblastoma cells through regulation of the PI3K/AKT signaling pathway.

Lei J, Yang J, Cheng S, Lu F, Wu Z, Wang Z Exp Ther Med. 2024; 28(6):447.

PMID: 39430343 PMC: 11487465. DOI: 10.3892/etm.2024.12737.

Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.

Wu J, Tang G, Cheng C, Yeerken R, Chan Y, Fu Z Mol Cancer. 2024; 23(1):218.

PMID: 39354529 PMC: 11443773. DOI: 10.1186/s12943-024-02136-2.

Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations.

Zhang Z, Li M, Zhang X, Zhou F Int J Nanomedicine. 2024; 19:9659-9688.

PMID: 39309188 PMC: 11416109. DOI: 10.2147/IJN.S479212.

References

Zamek-Gliszczynski M, Sangha V, Shen H, Feng B, Wittwer M, Varma M . Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance. Clin Pharmacol Ther. 2022; 112(3):485-500. DOI: 10.1002/cpt.2644. View

Bao T, Yin W, Zheng X, Zhang X, Yu J, Dong X . One-pot synthesis of PEGylated plasmonic MoO(3-x) hollow nanospheres for photoacoustic imaging guided chemo-photothermal combinational therapy of cancer. Biomaterials. 2015; 76:11-24. DOI: 10.1016/j.biomaterials.2015.10.048. View

Zheng J, Zhou T, Xu K, Li L . [Effect of Selaginella combined with radiotherapy on nasopharyngeal carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao. 2006; 26(2):247-8. View

Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M . Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020; 20(1):791. PMC: 7446227. DOI: 10.1186/s12885-020-07256-8. View

Sun X, Yu Q . Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol Sin. 2015; 36(10):1219-27. PMC: 4648179. DOI: 10.1038/aps.2015.92. View

Zou G, Zhang X, Wang L, Li X, Xie T, Zhao J . Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics. 2020; 10(15):6839-6853. PMC: 7295066. DOI: 10.7150/thno.43622. View

Li Z, Zhang G, Cao N, Xu J, Dong J, Li J . Effects of traditional Chinese medicine collaborative model (TCMCM) combined with adjuvant chemotherapy on IIIb and IIIc gastric cancer: a protocol for a randomized controlled trial. Trials. 2022; 23(1):68. PMC: 8781354. DOI: 10.1186/s13063-022-06013-5. View

Wan X, Yin Y, Zhou C, Hou L, Cui Q, Zhang X . Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants. Carbohydr Polym. 2021; 276:118739. DOI: 10.1016/j.carbpol.2021.118739. View

10.

Fu B, Wang N, Tan H, Li S, Cheung F, Feng Y . Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences. Front Pharmacol. 2018; 9:1394. PMC: 6281965. DOI: 10.3389/fphar.2018.01394. View

11.

Raj T, Smith A, Moore A . Vincristine sulfate liposomal injection for acute lymphoblastic leukemia. Int J Nanomedicine. 2013; 8:4361-9. PMC: 3826832. DOI: 10.2147/IJN.S54657. View

12.

Hu Z, Ott P, Wu C . Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat Rev Immunol. 2017; 18(3):168-182. PMC: 6508552. DOI: 10.1038/nri.2017.131. View

13.

Wu W, Shen J, Banerjee P, Zhou S . Water-dispersible multifunctional hybrid nanogels for combined curcumin and photothermal therapy. Biomaterials. 2010; 32(2):598-609. DOI: 10.1016/j.biomaterials.2010.08.112. View

14.

Pommier Y . Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006; 6(10):789-802. DOI: 10.1038/nrc1977. View

15.

Deng X, Shao Z, Zhao Y . Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy. Adv Sci (Weinh). 2021; 8(3):2002504. PMC: 7856884. DOI: 10.1002/advs.202002504. View

16.

Yang Q, Shi G, Chen X, Lin Y, Cheng L, Jiang Q . Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy. Theranostics. 2020; 10(18):8382-8399. PMC: 7381738. DOI: 10.7150/thno.45391. View

17.

Li Q, Wang G, Huang F, Li J, Cuff C, Reed E . Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs. Med Oncol. 2013; 30(1):488. DOI: 10.1007/s12032-013-0488-9. View

18.

De Jaeghere E, Tuyaerts S, Van Nuffel A, Belmans A, Bogaerts K, Baiden-Amissah R . Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study. Cancer Immunol Immunother. 2022; 72(2):475-491. PMC: 9870976. DOI: 10.1007/s00262-022-03253-x. View

19.

Xiang L, He B, Liu Q, Hu D, Liao W, Li R . Antitumor effects of curcumin on the proliferation, migration and apoptosis of human colorectal carcinoma HCT‑116 cells. Oncol Rep. 2020; 44(5):1997-2008. PMC: 7550984. DOI: 10.3892/or.2020.7765. View

20.

Kong G, Braun R, Dewhirst M . Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res. 2001; 61(7):3027-32. View